- Product Listings
- Compare Products
- Calculators
- Product Tours
- Expert Reviews
- Our Experts
- Company Directory
- About Beye
- Contact Us
Ⓒ 2024 Beye.com. All rights reserved.
This content is intended for health care professionals and providers only. The information contained on Beye.com, including text, graphics, images, and interactive activities, is for informational purposes only, and is not intended to be a substitute for professional medical advice. Beye LLC, via its Editors and Publisher, accepts no responsibility for any injury or damage to persons or property occasioned through the implementation of any ideas or use of any product described herein. Although great care is taken to ensure that all information is accurate, it is recommended that readers seek independent verification of advice on drugs and other product usage, surgical techniques and clinical processes prior to their use. References made in article may indicate usage of medical equipment or drugs at dosages, for periods of time, and in combination not included in the current prescribing information. Inclusion of advertising materials on the website thereof, does not constitute and representation or guarantee by Beye LLC of the quality of such products, or of the claims made.
iStent Trabecular Micro-Bypass
GlaukosThe iStent is engineered to fit into Schlemm canal, enabling steady physiologic outflow from a snorkel projecting into the anterior chamber. The self-trephinating tip guides device through the trabecular meshwork while retention arches secure placement.
At-a-Glance
- Material: Surgical-grade Nonferromagnetic Titanium with heparin coating
- The device measures 1 mm in length, 0.33 mm in height, and has a 120 micron lumen diameter
- Preservation of the trabecular meshwork ensures a natural episcleral back pressure of 8-11 mm Hg with minimal risk of hypotony
Related Products
Details
FDA
Yes
CE Mark
Yes
Classification
Ab interno
Indication
For use in conjunction with cataract surgery for the reduction of IOP in adult patients with mild to moderate open-angle glaucoma currently treated with ocular hypotensive medication
Mechanism of Action
Creates a channel through trabecular meshwork to enable aqueous humor to flow from the anterior chamber into the Schlemm’s canal
Usage
Treatment of mild to moderate glaucoma at the time of cataract surgery in patients as indicated
User Ratings + Reviews
Great way to do a combined cataract and glaucoma surgery! You can easily lower your patient's IOP without the trauma associated with traditional filtering procedures.
Very atraumatic insertion after the initial learning curve. Excellent safety profile. My patients have averaged 1.5 medication decrease concurrent with cataract surgery.
The iStent has an excellent safety profile. Even for novice surgeons, it requires very little additional time added to traditional cataract surgery. Patients who are taking only 1 glaucoma medication, in my opinion, benefit most since they have the added convenience of not having to do medications daily.
Like the idea and the engineering. Still in the learning curve.
Show More
Company Information
Contact the company for additional information, availability, or pricing:
Glaukos
glaukos.com229 Avenida Fabricante
San Clemente, CA 92672
Trending in Glaucoma
Powered by:
On the Front Lines of MIGS
Andrew A. Kao, MD
MillennialEye, May/June '18
Glaucoma Research Highlights
MillennialEye, May/June '18
Davinder S. Grover, MD, MPH
Davinder S. Grover, MD, MPH
CRSToday, April 2018
Pseudophakic Bullous Keratopathy
CRSToday, April 2018
MIGS: A Crash Course
Constance O. Okeke, MD, MSCE
CollaborativeEye, Mar/Apr '18
MIGS: The New Glaucoma Paradigm
Robert S. Stutman, OD, MBA, FAAO
CollaborativeEye, Mar/Apr '18
Persistent LASIK Flap Interface Fluid After DSAEK Procedure
CRSToday, February 2018
MIGS Update
CRSToday, Sep 2016
Show More
